Phase 2/3 trial of Oravax's COVID-19 vaccine
Latest Information Update: 18 Jan 2022
At a glance
- Drugs COVID-19 vaccine-Oravax Medical (Primary)
- Indications COVID 2019 infections
- Focus Registrational; Therapeutic Use
- Sponsors Oramed Pharmaceuticals
- 12 Jan 2022 According to an Oramed Pharmaceuticals media release, Initiation of Phase 2/3 oral COVID-19 vaccine trials expected H2 2022.
- 08 Nov 2021 New trial record
- 29 Oct 2021 According to an Oramed Pharmaceuticals media release, the company expect to initiate this study for emergency use approval in relevant countries.